Interferon-modification of the in vitro Radiation Response in Cultured Human KNS-42 Cells

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The efficacy of combined interferon radiation therapy in cultured human KNS-42 glioma cells was examined. Beta- type human fibroblast interferon inhibited the multiplication of KNS-42 cells in a dose-dependent manner. The inhibitory effect was thought to be due to supression of the cells entering the S-phase. KNS-42 cells were treated with interferon before or after irradiation. The effect of the treatments was assayed by growth and survival curves. According to a cell growth analysis, the combined treatment had a greater antiproliferative effect than the radiation or the interferon treatment alone. When interferon was given before irradiation, it tended to reduce the shoulder of the X-ray survival curve in a dose-dependent manner until the shoulder totally disappeared. The slope itself, however, was only moderately affected by interferon. The mechanism of this synergistic interaction between interferon and X-rays was possibly due to a partial synchronizing effect of interferon on the cells by blocking them in a G1/S boundary phase, the radiosensitive stage of the cell cycle. When interferon was given immediately after irradiation, it tended to reduce the slope in a dose-dependent manner. The shoulder disappeared almost totally even with a low dose of interferon. These results suggest that interferon may be useful as a radiosensitizing agent in tumor therapy. © 1984, The Japan Neurosurgical Society. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Korosue, K., Tamaki, N., Matsumoto, S., Takeshita, I., & Fukui, M. (1984). Interferon-modification of the in vitro Radiation Response in Cultured Human KNS-42 Cells. Neurologia Medico-Chirurgica, 24(4), 233–239. https://doi.org/10.2176/nmc.24.233

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free